Assignee
PLEXXIKON INC
US·85 granted patents·35 pending applications·2,726 citations·filing 2003–2024
Top patents by PatentIndex Score
120 records- 0199US9487515B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2015·Granted Nov 8, 2016·44 cites·15 claims
- 0299US9469640B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Oct 18, 2016·44 cites·12 claims
- 0399US7893075B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2007·Granted Feb 22, 2011·96 cites·22 claims
- 0499US7498342B2Compounds modulating c-kit activityPLEXXIKON INC·Filed 2005·Granted Mar 3, 2009·80 cites·11 claims
- 0598US9550768B2Kinase modulation and indications thereforPLEXXIKON INC·Filed 2013·Granted Jan 24, 2017·41 cites·6 claims
- 0698US9260437B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Feb 16, 2016·100 cites·4 claims
- 0798US8722702B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2013·Granted May 13, 2014·60 cites·16 claims
- 0898US7947708B2Compounds modulating C-kit activityPLEXXIKON INC·Filed 2008·Granted May 24, 2011·52 cites·22 claims
- 0998US7863288B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2006·Granted Jan 4, 2011·187 cites·54 claims
- 1098US7476746B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Jan 13, 2009·61 cites·16 claims
- 1197US9844539B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 19, 2017·20 cites·30 claims
- 1297US9771369B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Granted Sep 26, 2017·24 cites·18 claims
- 1397US9730918B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Aug 15, 2017·25 cites·3 claims
- 1497US9695169B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2015·Granted Jul 4, 2017·26 cites·20 claims
- 1597US9358235B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 7, 2016·41 cites·3 claims
- 1697US9169250B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2014·Granted Oct 27, 2015·36 cites·17 claims
- 1797US7863289B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2007·Granted Jan 4, 2011·131 cites·24 claims
- 1897US7846941B2Compounds modulating c-kit and c-fms activity and uses thereforPLEXXIKON INC·Filed 2006·Granted Dec 7, 2010·92 cites·9 claims
- 1997US7723374B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted May 25, 2010·54 cites·11 claims
- 2097US7572806B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Aug 11, 2009·59 cites·5 claims
- 2197US7504509B2Compounds and methods for development of Ret modulatorsPLEXXIKON INC·Filed 2004·Granted Mar 17, 2009·153 cites·39 claims
- 2297US7491831B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Feb 17, 2009·56 cites·17 claims
- 2397US7348338B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Mar 25, 2008·79 cites·9 claims
- 2496US9822109B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2015·Granted Nov 21, 2017·23 cites·14 claims
- 2596US9802932B2Solid forms of a compound modulating kinasesPLEXXIKON INC·Filed 2016·Granted Oct 31, 2017·21 cites·14 claims
- 2696US9776998B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2016·Granted Oct 3, 2017·20 cites·12 claims
- 2796US9771363B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2016·Granted Sep 26, 2017·34 cites·20 claims
- 2896US9617267B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Apr 11, 2017·38 cites·6 claims
- 2996US9440969B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Sep 13, 2016·40 cites·19 claims
- 3096US9150570B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2013·Granted Oct 6, 2015·35 cites·10 claims
- 3196US9096593B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Aug 4, 2015·34 cites·22 claims
- 3296US8367828B2PPAR active compoundsPLEXXIKON INC·Filed 2010·Granted Feb 5, 2013·54 cites·7 claims
- 3396US7872018B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2007·Granted Jan 18, 2011·48 cites·12 claims
- 3496US7585859B2PDE4B inhibitors and uses thereforPLEXXIKON INC·Filed 2005·Granted Sep 8, 2009·67 cites·9 claims
- 3595US10899761B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2020·Granted Jan 26, 2021·4 cites·6 claims
- 3695US10435404B2Formulations of a compound modulating kinasesPLEXXIKON INC·Filed 2018·Granted Oct 8, 2019·11 cites·20 claims
- 3795US10370374B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2018·Granted Aug 6, 2019·17 cites·22 claims
- 3895US9975894B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted May 22, 2018·20 cites·21 claims
- 3995US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 4095US9745298B2Synthesis of a compound that modulates kinasesPLEXXIKON INC·Filed 2016·Granted Aug 29, 2017·22 cites·3 claims
- 4195US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 4295US9682981B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jun 20, 2017·25 cites·14 claims
- 4395US9663517B2Compositions and uses thereofPLEXXIKON INC·Filed 2016·Granted May 30, 2017·31 cites·5 claims
- 4495US8053463B2PPAR active compoundsPLEXXIKON INC·Filed 2008·Granted Nov 8, 2011·45 cites·8 claims
- 4595US7605168B2PDE4B inhibitorsPLEXXIKON INC·Filed 2005·Granted Oct 20, 2009·62 cites·16 claims
- 4695US7531568B2PPAR active compoundsPLEXXIKON INC·Filed 2005·Granted May 12, 2009·51 cites·12 claims
- 4795US7202266B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Apr 10, 2007·65 cites·54 claims
- 4894US10160755B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 25, 2018·15 cites·14 claims
- 4994US9994567B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2017·Granted Jun 12, 2018·14 cites·7 claims
- 5094US9856259B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2015·Granted Jan 2, 2018·20 cites·20 claims
Showing the top 50 of 120 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PLEXXIKON INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →